AXGT Market Cap History Table | ||||||||||||||||||
Also see: AXGT Shares Outstanding History and AXGT YTD Return |
AXGT Market Cap History Table | ||||||||||||||||||
Also see: AXGT Shares Outstanding History and AXGT YTD Return |
AXGT Market Cap History Chart | ||||||||||||||||||||||||
-21.42% CAGR Mouse over chart for data details
|
AXGT Stock Price Chart |
About Sio Gene Therapies Inc |
Sio Gene Therapies is a clinical-stage biopharmaceutical company focused on gene therapy for neurological diseases. Co. is developing a pipeline of product candidates as the following: AXO-Lenti-PD, which is developed for the treatment of Parkinson's disease; AXO-AAV-GM1, which is an investigational gene therapy that is being developed as a potential one-time disease modifying treatment for GM1 gangliosidosis; and AXO-AAV-GM2, which is an investigational gene therapy that Co. is developing as a potential one-time disease modifying treatment for GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease). We show 8 historical shares outstanding datapoints in our AXGT shares outstanding history coverage, used to compute AXGT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AXGT market cap history over the course of time is important for investors interested in comparing AXGT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AXGT versus a peer is one thing; comparing AXGT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AXGT can fluctuate over the course of history. With this page we aim to empower investors researching AXGT by allowing them to research the AXGT market cap history. |
AXGT Current Stock Quote |
Free AXGT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
AXGT Share Performance |
Market Cap Peers |
Axovant Gene Therapies (AXGT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AXLA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.